Sign inJoin waitlistJoin the waitlist

Biruh Workeneh

Associate Professor · University of Texas M D Anderson Cancer Center

Credentials: · · · · · · · ·

History

University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

Nephrology
Stanford University
2007–2008
Internal Medicine
The University of Texas Medical Branch at Galveston
2002–2005
McGovern Medical School at The University of Texas Health Science Center at Houston
1998–2002
University of Texas at Austin
1998

Research

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
Journal for ImmunoTherapy of Cancer · 2019 · 219 citations
Review of muscle wasting associated with chronic kidney disease
Review · American Journal of Clinical Nutrition · 2010 · First of 2 authors · 212 citations
Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486
Kidney International · 2012 · 194 citations

William Mitch
9 papers
Helbert Rondon
7 papers · 1 as a fellow
KJ
Kenar Jhaveri
5 papers
Ala Abudayyeh
3 papers
NU
Nupur Uppal
3 papers
Omar Mamlouk
3 papers · 2 as a fellow
Sreedhar Mandayam
3 papers
Yvonne Sada
3 papers
AA
Abdul Abdellatif
2 papers
Amanda Renaghan
2 papers · 2 as a resident
Amanda Tchakarov
2 papers
Arash Rashidi
2 papers

Clinical trials

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Site PI · Recruiting · Phase 3
Biogen
2025–2029
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Site PI · Recruiting · Phase 1, Phase 2
Cabaletta Bio
2024–2029
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Site PI · Recruiting · Phase 2
Novartis Pharmaceuticals
2022–2028
Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease
Site PI · Unknown · Phase 2
Angion Biomedica Corp
2021–2023